Aerpio Pharmaceuticals, Inc. announced that Joseph Gardner, Muneer Satter, Paul M. Weiss, Caley Castelein, Anupam Dalal, Steven Prelack, Chau Khuong, and Pravin Dugel were appointed to the board of directors. Also Joseph Gardner was appointed as President and Chief Executive Officer, James Murphy was appointed as Interim Chief Financial Officer, Kevin G. Peters was appointed as Chief Scientific Officer, and Stephen Pakola was appointed as Chief Medical Officer by board of directors. Joseph Gardner will be principal executive officer and James Murphy will be principal financial and accounting officer for SEC reporting purposes.